drugset
drugset / Trial / NCT00762749

Study to Evaluate Diphenhydramine in Children and Adolescents

NCT00762749 ↗

Phase 1 Completed 36 enrolled Johnson & Johnson Consumer and Personal Products Worldwide
Non-randomizedSingle-groupOpen-labelBasic science

Summary

To characterize the pharmacokinetics of diphenhydramine in two pediatric populations: children, ages 2 to \< 12 years, and adolescents, ages 12 to \< 18 years.

Timeline

Start
2008-09
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Unknown 12.5 mg —

Indications

allergic rhinitis